Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-02-22 @ 6:37 PM
Study NCT ID:
NCT02715258
Status:
COMPLETED
Last Update Posted:
2021-06-28
First Post:
2016-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Sponsor:
Theracos
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
THR-1442-C-450
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None